申请人:Merck & Co., Inc.
公开号:US04777281A1
公开(公告)日:1988-10-11
The invention relates to novel [(3,4-dichloro-6,7,8,8a,9,10-hexahydro-6-oxo-8a-substituted-2-phenanthreny l)ox yl]-alkanoic acids and -ethanimidamides and their salts. The compounds are useful for the treatment and prevention of injury to the brain and of edema due to head trauma, stroke (particularly ischemic), arrested breathing, cardiac arrest, Reye's syndrome, cerebral thrombosis, cerebral embolism, cerebral hemorrhage, cerebral tumors, encephalomyelitis, spinal cord injury, hydrocephalus, post-operative brain injury trauma, edema due to cerebral infections and various brain concussions.
该发明涉及新型[(3,4-二氯-6,7,8,8a,9,10-六氢-6-氧-8a-取代-2-苯并基氧基)-烷酸和-乙烯酰胺以及它们的盐。这些化合物可用于治疗和预防脑部损伤和由头部创伤、中风(特别是缺血性)、呼吸停止、心脏骤停、莱耶综合征、脑血栓形成、脑栓塞、脑出血、脑肿瘤、脑脊髓炎、脊髓损伤、脑积水、术后脑损伤创伤、脑部感染引起的水肿和各种脑震荡引起的水肿。